Pharming Group N.V.
- PHAR
- NASDAQ
- Biotechnology
- Rare Disease Biopharma
- Protein Replacement Therapy
- Precision Medicines
$9.29
Today −0.75%Quote Oct 19, 2026, 03:24 PM UTC
−13.17%over the last month
Max drawdown −16.9%From 1-month high −16.9%3 months −28.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$6.52B
Quote Oct 19
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$39.00
+319.8% from here
Floor
$9.13
1.7% below price
Where the price sits
3 analysts
Analyst range, low to high
$38.00$40.00
- Price $9.29
- Resistance $9.28–$9.37
- Consensus $39.00
The price is just above its floor. Analysts' average target sits about 320% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PHARPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
407